Literature DB >> 11685454

The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.

T M Tran1, P Ivanyi, I Hilgert, T Brdicka, M Pla, B Breur, M Flieger, E Ivasková, V Horejsí.   

Abstract

A broadly used pan-HLA class I-reactive monoclonal antibody W6/32 is believed to recognize a conformational epitope dependent on association between heavy chains and beta2-microglobulin (beta2m). However, in the present study we report that W6/32 does recognize at least some free HLA class I heavy chains under the partially denaturating conditions of nonreducing Western blotting, namely nearly all HLA-B allelic products. Furthermore, we confirm and largely extend our previous observation that complexes of beta2m with heavy chains of a few HLA class I allelic forms (most notably HLA-B27) exhibit unusual resistance to dissociation by SDS, which is reminiscent of MHC class II molecules. In addition, our data indicate the existence of covalent (disulfide-linked) heterodimers of certain HLA class I heavy chains (namely Cw1 and Cw4) and beta2m.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685454     DOI: 10.1007/s002510100353

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  12 in total

1.  Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27.

Authors:  Begoña Galocha; José A López de Castro
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

2.  Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.

Authors:  N M Valenzuela; K R Trinh; A Mulder; S L Morrison; E F Reed
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

3.  Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.

Authors:  Fengwen Zhang; Trinity Zang; Eva M Stevenson; Xiao Lei; Dennis C Copertino; Talia M Mota; Julie Boucau; Wilfredo F Garcia-Beltran; R Brad Jones; Paul D Bieniasz
Journal:  bioRxiv       Date:  2022-05-26

4.  Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells.

Authors:  Richard Apps; Lucy Gardner; Sue E Hiby; Andrew M Sharkey; Ashley Moffett
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

5.  HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs.

Authors:  Nicole M Valenzuela; Arend Mulder; Elaine F Reed
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

6.  The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (β2M) affecting antigen presentation function of macrophage.

Authors:  Gopalkrishna Sreejit; Asma Ahmed; Nazia Parveen; Vishwanath Jha; Vijaya Lakshmi Valluri; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  PLoS Pathog       Date:  2014-10-30       Impact factor: 6.823

7.  Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.

Authors:  Craig J Taylor; Vasilis Kosmoliaptsis; Jessie Martin; Graham Knighton; Dermot Mallon; J Andrew Bradley; Sarah Peacock
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

8.  Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells.

Authors:  Kattria van der Ploeg; Chiwen Chang; Martin A Ivarsson; Ashley Moffett; Mark R Wills; John Trowsdale
Journal:  Front Immunol       Date:  2017-03-29       Impact factor: 7.561

9.  Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.

Authors:  Aurelia Jud; Monika Kotur; Christoph Berger; Claudine Gysin; David Nadal; Anna Lünemann
Journal:  Oncotarget       Date:  2017-01-24

10.  Increased expression of beta 2-microglobulin in multidrug-resistant tumour cells.

Authors:  G L Scheffer; M C de Jong; A Monks; M J Flens; C D Hose; M A Izquierdo; R H Shoemaker; R J Scheper
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.